Drugs / rATG
last change Nov 2018 re-read 2 minutes ago

rATG

Protein / enzyme biologic

Developed for
neuromyelitis optica
Investigated by
Northwestern University

Trials 1 · a red edge is where a trial was stopped

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00787722 Oct 2009 → Nov 2018 neuromyelitis optica Northwestern University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rATG ClinicalTrials.gov intervention name — accepted as the source's own label NCT00787722
Modality Protein / enzyme biologic “A rabbit polyclonal antibody to lymphocytes” NCT00787722